Matt Truman
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 13
- HER2/EGFR in Cancer Research 5
- Lung Cancer Research Studies 4
- Colorectal Cancer Treatments and Studies 3
-
- Lung Cancer Treatments and Mutations 6
- Co-authors
- Chong‐Jen Yu (5 shared papers)Tony Mok (5 shared papers)Yi‐Long Wu (5 shared papers)Barbara Klughammer (4 shared papers)Vichien Srimuninnimit (4 shared papers)Guia Ladrera (4 shared papers)Virote Sriuranpong (4 shared papers)Sumitra Thongprasert (4 shared papers)
- Journals
- Lupus Science & Medicine (3 papers)Annals of Oncology (2 papers)Journal of Clinical Oncology (2 papers)Cancer Research (2 papers)Blood (1 paper)
- Partner nations
- AustraliaSwitzerlandUnited States
In The Last Decade
Matt Truman
24 papers receiving 625 citations
Hit Papers
Peers
Comparison fields: 5 of 53
- Cancer Research 337
- Pulmonary and Respiratory Medicine 393
- Transplantation 30
- Oncology 269
- Nephrology 52
Countries citing papers authored by Matt Truman
This map shows the geographic impact of Matt Truman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matt Truman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matt Truman more than expected).
Fields of papers citing papers by Matt Truman
This network shows the impact of papers produced by Matt Truman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matt Truman. The network helps show where Matt Truman may publish in the future.
Co-authors
The 25 scholars most cited alongside Matt Truman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy Hit paper breakdown → | 2015 | 367 |
| 2 | 2015 | 39 | |
| 3 | 2009 | 32 | |
| 4 | 2014 | 24 | |
| 5 | 2018 | 24 | |
| 6 | 2016 | 22 | |
| 7 | 2012 | 21 | |
| 8 | 2019 | 19 | |
| 9 | 2012 | 13 | |
| 10 | 2019 | 11 | |
| 11 | 2008 | 11 | |
| 12 | 2019 | 11 | |
| 13 | 2013 | 9 | |
| 14 | 2022 | 8 | |
| 15 | 2016 | 6 | |
| 16 | 2017 | 4 | |
| 17 | 2016 | 3 | |
| 18 | 2016 | 2 | |
| 19 | 2024 | 1 | |
| 20 | 2016 | 1 |
About Matt Truman
Matt Truman is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Rheumatology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 25 papers that have together received 632 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (6 papers), HER2/EGFR in Cancer Research (5 papers), Systemic Lupus Erythematosus Research (5 papers), Breast Cancer Treatment Studies (4 papers), Lung Cancer Research Studies (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Liver Diseases and Immunity (3 papers). The work is most often cited by research in Cancer Research (337 citations), Pulmonary and Respiratory Medicine (393 citations), Transplantation (30 citations), Oncology (269 citations) and Nephrology (52 citations). Matt Truman has collaborated with scholars based in Australia, Switzerland and United States. Frequent co-authors include Chong‐Jen Yu, Tony Mok, Yi‐Long Wu, Barbara Klughammer, Vichien Srimuninnimit, Guia Ladrera, Virote Sriuranpong, Sumitra Thongprasert, Jennifer Sandoval-Tan and David S. Shames. Their work appears in journals such as Lupus Science & Medicine, Annals of Oncology, Journal of Clinical Oncology, Cancer Research and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.